PeptiDream Announces Collaboration, License Agreement with Lilly

By: Benzinga
PeptiDream (PeptiDream)(TOKYO:4587), announced that they have entered into a Collaboration and License Agreement with US-based Eli Lilly and Company (Lilly)(NYSE: LLY ) on 19 December 2013. Under the
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.